ProCE Banner Activity

CE / CME

Rise of the Resistance: Challenging Carbapenem-Resistant Gram-Negative Infections

Video

On-demand webcast of expert faculty presentation and case discussion on strategies to manage carbapenem-resistant gram-negative infections according the current guidelines.

Nurses: 1.50 Nursing contact hours

Pharmacists: 1.50 contact hours (0.15 CEUs)

Physicians: maximum of 1.50 AMA PRA Category 1 Credits

Released: November 04, 2024

Expiration: November 03, 2025

Share

Faculty

Marguerite L. Monogue

Marguerite L. Monogue, PharmD, BCIDP

Infectious Diseases Pharmacy Specialist
Assistant Professor, Department of Internal Medicine
University of Texas Southwestern
Dallas, Texas

Michael J. Satlin

Michael J. Satlin, MD, MS, FIDSA

Associate Professor of Medicine
Clinical Director, Transplant-Oncology Infectious Diseases Program
Weill Cornell Medicine
New York, New York

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Shionogi Pharma, Inc.

Shionogi Pharma, Inc.

Target Audience

This program is intended for HCPs involved in the management of carbapenem-resistant gram-negative infections including ID and critical care specialist physicians, nurses, and clinical pharmacists.

Program Learning Goal

The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with infectious diseases.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Select empiric and targeted antibiotic regimens for carbapenem-resistant Enterobacterales infections integrating regional and institutional epidemiologic data and risk factors for antimicrobial resistance

  • Apply best practices for the antibiotic management of complex infections involving Stenotrophomonas maltophilia

  • Design antibiotic regimens to achieve therapeutic targets for carbapenem-resistant Pseudomonas aeruginosa infections in critically ill patients

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Marguerite L. Monogue, PharmD, BCIDP

Infectious Diseases Pharmacy Specialist
Assistant Professor, Department of Internal Medicine
University of Texas Southwestern
Dallas, Texas

Marguerite L. Monogue, PharmD, BCIDP: researcher: Shionogi.

Michael J. Satlin, MD, MS, FIDSA

Associate Professor of Medicine
Clinical Director, Transplant-Oncology Infectious Diseases Program
Weill Cornell Medicine
New York, New York

Michael J. Satlin, MD, MS, FIDSA: data and safety monitoring board: AbbVie; researcher: Biomerieux, Merck, SNIPRBiome.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.5 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from November 04, 2024, through November 03, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.

  2. Read the target audience, learning objectives, and faculty disclosures.

  3. View and study the content in its entirety.

  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-24-312-H01-P 

Type of Activity: Application 

Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.